Heavy Heatwave Risk: Why High Blood Pressure Patients Should Reach for Water, Not Naengmyeon Broth
As extreme heat continues across South Korea, with Seoul’s daytime high forecast to hit 39°C on August 7—Ipchu, the traditional seasonal marker...
Search results for "SGLT-2 inhibitor"
Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients
Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient: inavogliflozin), has shown...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Mexico Greenlights Daewoong’s Envlo, Fueling Latin American Expansion
Daewoong Pharmaceutical announced on May 27 that its type 2 diabetes treatment, Envlo 0.
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
"Diabetes Medication, Thought to Only Control Blood Sugar"... Can It Also Alter Cancer Growth?
Medications widely used as diabetes treatments have raised the possibility of influencing the occurrence and...
1